VP, Pharmaceutical Quality at Dyno Therapeutics

Waltham, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, BiotechnologyIndustries

Requirements

Bachelor’s degree in science or a related field; advanced degree strongly preferred
15+ years’ experience in the pharmaceutical or biotechnology industry in cGMP quality and compliance role
5+ years’ experience as a functional head of a quality department
Strong cGMP knowledge in the pharmaceutical industry and implementing a phase-appropriate cGMP quality system
Hands-on experience with implementing and managing Quality/Compliance systems and processes (infrastructure)
Proven record of developing and maintaining successful working relationships with regulatory agencies
Demonstrated understanding of the principles and applications associated with external manufacturing operations from development to clinical manufacturing
Strong experience and knowledge of cGMP manufacturing and stability to support BLAs/NDAs
Strategic thinker with strong result-orientation and a sense of urgency to deliver quality results on time and in a highly ethical and professional manner
Experience managing complex schedules and priorities in dynamic pharmaceutical environment

Responsibilities

Design, implement and maintain cGMP QA and QC programs, and the compliance infrastructure, including the cGMP-related SOP system, training programs, and performing internal and external audits
Work with the company’s external suppliers including clinical manufacturing organizations (CMOs) and contract labs to ensure consistent cGMP quality and compliance
Direct development and implementation of cGMP quality systems to ensure product reliability, quality, efficacy, compliance with applicable SOPs, cGMP regulations; phase-appropriate quality systems and approach
Lead resolution of product complaint, OOS and OOT investigations in phase-appropriate manner; lead and manage Material Review Board (MRB)
Lead setting up and managing stability program for pre-commercial and commercial products; data analyses and stability sections of regulatory filings
Oversee cGMP compliant auditing program to fulfill regulatory requirements
Develop, manage and monitor adherence to the overall Quality and Compliance at Dyne
Develop, analyze and report business metrics and highlights; manage department budget
Manage inspections by the FDA, other regulatory agencies and commercial partners at CMOs
Lead quality input on contracts and serve as the primary contact for the negotiation of quality agreements
Manage and build a team suitable for the growing needs of the organization

Skills

cGMP

Quality Assurance

Quality Control

SOP

Auditing

Regulatory Compliance

GMP

CMO Management

Contract Labs

Internal Audits

External Audits

Regulatory Filings

Inspections

Dyno Therapeutics

Develops AI-optimized gene therapy vectors

About Dyno Therapeutics

Dyno Therapeutics focuses on advancing gene therapy by utilizing Artificial Intelligence to create Adeno-associated virus (AAV) vectors. These vectors are essential tools for delivering genetic material into cells, which is crucial for effective gene therapy. The company's AI technology enables the design and optimization of these vectors, potentially enhancing the success of gene therapies. Dyno collaborates with major pharmaceutical and biotech companies, such as Astellas, Roche, Sarepta, and Novartis, to develop therapies for various diseases affecting the skeletal and cardiac muscles, central nervous system, liver, and eyes. Unlike many competitors, Dyno's unique approach leverages AI to improve the performance of AAV vectors, setting it apart in the biotech field. The company's goal is to improve gene therapy outcomes through its advanced vector technology, ultimately benefiting patients with serious health conditions.

Watertown, MassachusettsHeadquarters

2018Year Founded

$106MTotal Funding

SERIES_ACompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Remote Work Options

Risks

Gene therapy investment slowdown may impact Dyno's growth and innovation.

Manufacturing bottlenecks could hinder scaling of Dyno's operations.

Increased competition from companies like Form Bio challenges Dyno's market position.

Differentiation

Dyno uses AI to design optimized AAV vectors for gene therapy.

Their AI-driven CapsidMap platform enhances AAV vector development for muscle gene therapies.

Partnerships with major pharma companies like Astellas and Roche boost Dyno's market presence.

Upsides

AI-driven capsid design improves delivery efficiency and reduces manufacturing costs.

Collaboration with NVIDIA enhances biological sequence design for gene therapies.

Generative AI increases efficiency of eye and brain-targeted capsid delivery significantly.

Land your dream remote job 3x faster with AI

Try Jobo Free